Abstract. Brain coenzyme Q 10 (CoQ 10 ) concentration can influence the activity of several brain regions, including those which participate in the regulation of cardiovascular circadian rhythms, food intake, neuroendocrine stress response, activity and sleep regulation. However, the effect of supplemented ubiquinol (reduced CoQ) into brain regions is not known. This study determined baseline levels of ubiquinone (oxidized CoQ) in various rat brain regions and proved the bioavailability of the liposomal ubiquinol to selected brain regions after its administration into right brain ventricle. Our data indicate that administration of ubiquinol may create the basis for modulation of neuronal activities in specific brain regions.
Both coenzyme Q 10 (CoQ 10 ) forms, ubiquinol -reduced CoQ 10 and ubiquinone -oxidized CoQ 10 , play a vital role in mitochondrial ATP production and contribute to antioxidant protection in the organism. Ubiquinol is one of the most powerful lipophilic antioxidants, capable of regenerating other antioxidants, such as tocopherol and ascorbate. Ubiquinol gives up electrons to neutralize free radicals, it can inhibit the initiation step and interfere with the propagation step of lipid and protein oxidation (Bentinger et al. 2007 ). CoQ 10 is the predominant form in humans, while in rats and mice it is CoQ 9 (Ebadi et al. 2001 ). In whole rat brain tissue the baseline concentration of CoQ 9 is higher in comparison with CoQ 10 , yet information about their concentrations in rat brain regions is poor. Localization of fourteen brain regions is shown in Fig. 1 . CoQ concentration in brain regions can influence the regulation of heart circadian rhythms, the regulation of food intake, neuroendocrine stress response, regulation of activity and sleep. In diseases or ageing, when the human body produces insuficient amount of CoQ 10 , the organism calls for its supplementation (Haas 2007; Littarru and Tiano 2010) . The authors (Bhagavan and Chopra 2006) reviewed animal data showing that dosage and duration of CoQ 10 administration are important factors for uptake by brain and heart, as well as by other tissues. Another study found superior bioavailability of the solubilized formulation of both ubiquinone and ubiquinol in plasma compared to unsolubilized CoQ 10 (Bhagavan and Chopra 2007) . The mechanism of supplemented CoQ 10 effect on brain regions and its function is not clear to date. Our previous studies showed stimulation of brain and heart mitochondrial function in an animal model of Alzheimer´s disease after ubiquinone administration (Horecký et al. 2008) . However, the uptake of ubiquinol to brain structures has not been elucidated yet. Concerning this we decided to investigate the uptake of administered ubiquinol by rat brain ventricular regions within the period of 15 to 120 minutes.
Liposomal ubiquinol was administered intracerebroventricularly (40 µl of 10% ubiquinol) into the right lateral ventricle of 3-month-old rats, which were sacrificed at selected time intervals. The control group (represents time zero minutes) consisted of three animals and each of the four ubiquinol groups (represent effect of administered ubiquinol during 15, 30, 60 or 120 minutes ) consisted of two animals. Brains were removed after 15, 30, 60 or 120 minutes after ubiquinol administration. Each brain region has its own special function ( Fig. 1 ). Basal ganglia (BG) participate in signal transduction from the circulation to neurons; organum vasculosum laminae terminalis (OVLT) participate in signal transduction from the systemic circulation to the brain tissue; subfornical organ (SF) is sensory circumventricular organ; nucleus supraopticus (NSO) contains neurons releasing vasopressin and oxytocin into the systemic circulation, regulation of osmolality), nucleus suprachiasmaticus (NSCH) is the main pacemarker regulating heart circadian rhythms; nucleus paraventricularis (PVN) coordinate autonomic, neuroendocrine and immune reactions; nucleus ventromedialis (NVM) regulate food intake; nucleus dorsomedialis (NDM) regulate autonomic nervous system activity and food intake; substantia nigra (SN) regulate motor functions; cortex (CX) is responsible for cognitive function; area posterema (AP) is sensory circumventricular organ; nucleus tractus solitarii (NTS) is main relay station processing visceral and gustatory signals; noradrenergic cell group A5 (A5) regulate autonomic nervous system activity, modulate nociception; locus coerulues (LC) is the main source of brain norepinephrine, regulate vigilance, attention, and stress response. Using the microdissection method we received slices from 14 regions of each brain and used to measure the levels of CoQ (Fig. 1) . Each brain region included the following number of slices per wet weight (ww): BG (10 slices/4.90 mg ww), OVLT (3 slices/1.20 mg ww), NSO (4 slices/0.72 mg ww), NSCH (4 slices/0.72 mg ww), PVN (6 slices/1.08 mg ww), NVM (10 slices/4.00 mg ww), NDM (10 slices/4.00 mg ww), SN (20 slices/4.00 mg ww), CX (10 slices/9.80 mg ww), NTS (10 slices/1.80 mg ww), A5 (4 slices/0.72 mg ww), LC (6 slices/1.08 mg ww), SFO (3 slices/0.54 mg ww) and AP (3 slices/0.54 mg ww).
Oxidized ubiquinone CoQ 10-OX and CoQ 9-OX concentrations in brain regions were determined by HPLC method using UV detector at 275 nm (Lang et al. 1986 ) with some modifications (Kucharská et al. 1998) . Each value represents the mean concentration of CoQ 10-OX or CoQ 9-OX in samples obtained from two or three rat brain. Concentrations of CoQ are calculated in nmol/g ww. Measurements of CoQ 10-OX (ubiquinone 10) and CoQ 9-OX (ubiquinone 9) concentrations in small samples of SFO and AP were below the limit of the HPLC with UV detection. Excel statistical functions were used for evaluation of mean ± SEM (standard error of Figure 1 . Scheme of rat brain regions. A5, A5 noradrenergic cell group; AP, area posterema; BG, basal ganglia, CX, cortex, LC, locus coeruleus; NDM, nucleus dorsomedialis; NSCH -nucleus suprachiasmaticus; NSO, nucleus supraopticus; NTS, nucleus tractus solitarii; NVM, nucleus ventromedialis; OVLT, organum vasculosum laminae terminalis; PVN, nucleus paraventricularis; SFO, subfornical organ; SN, substantia nigra. mean). In this pilot study with a small number of animals in groups,statistical significance was not evaluated. Male Wistar rats were carried out in accordance with the Veterinary and Food Administration of the Slovak Republic and by the Ethics Commitee. The rats were housed at 22 ± 2°C, 45% relative humidity, 12-h light/dark photoperiodicity in rooms with free access to standard laboratory chow and drinking water.
In our study we found differences in CoQ concentrations between individual regions. Administered ubiquinol increased CoQ 10-OX and CoQ 9-OX concentrations in studied regions. Maximum CoQ 10-OX concentration (compared with group without ubiquinol administration -time zero minutes) was found after 15 minutes in the following brain regions: NSO, NSCH, NVM, NDM and LC. After 60 minutes, the maximum CoQ 10-OX concentration was found in BG, PVN and CX, while after 120 minutes in OVLT and in SN. Administered ubiquinol increased CoQ 9-OX concentration in OVLT, NTS and A5 after 120 minutes and had no effect on CoQ 9-OX concentration in NVM, NDM and CX. Our data show higher baseline concentrations of CoQ 9-OX than of CoQ 10-OX in rat brain regions BG, OVLT, SN, CX, NTS, A5, but lower in NSCH, NVM, NDM and LC (Table 1) . These different CoQ levels could be connected with individual brain region functions.
The benefit of therapeutic supplementation of ubiquinol in neurodegenerative diseases depends also on its bioavailability. Significantly higher plasma CoQ 10 concentration was found in subjects aged over 60 years after supplementation with ubiquinol in comparison with ubiquinone (Hosoe et al. 2007) . For the first time has been demonstrated beneficial effect of ubiquinol on psychological manifestation in autistic children (Gvozdjáková et al. 2012) .
This study determined baseline levels of CoQ 10-OX and CoQ 9-OX in various rat brain regions and proved the 33.00 ± 1.75 Data are expressed as mean ± SEM; n.d., not detectable; CoQ 10-OX , ubiquinone 10; CoQ 9-OX , ubiquinone 9; BG, basal ganglia; OVLT, organum vasculosum laminae terminalis; NSO, nucleus supraopticus; NSCH, nucleus suprachiasmaticus; PVN, nucleus paraventricularis; NVM, nucleus ventromedialis; NDM, nucleus dorsomedialis; SN, substantia nigra; CX, cortex; NTS, nucleus tractus solitarii; A5, A5 noradrenergic cell group; LC, locus coeruleus. bioavailability of the liposomal ubiquinol to selected brain regions after its administration into the right brain ventricle. Our results may contribute to the elucidation of ubiquinol effects on brain function.
